DRW Securities’s Gilead Sciences GILD Stock Holding History

DRW Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,400	Closed	-$321K	–	284
2022 Q1	$321K	Buy	+5,400	New	+$345K	0.01%	199

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRW Securities's GILD Position: Q2 2026 in Review

DRW Securities sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 3,207 shares — an estimated $438K sold.

DRW Securities first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $6.13M in Q4 2014. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

DRW Securities reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 3,207 Gilead Sciences shares in Q2 2026, an estimated $438K.
DRW Securities first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
DRW Securities's Gilead Sciences position peaked at $6.13M in Q4 2014.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.